MEPHARMA and PharmaLex Collaborate to Elevate Pharma Services in the Middle East

PharmaLex and MEPHARMA have forged a strategic partnership to enhance services in the pharmaceutical, biotech, and medical device sectors across the Middle East. This collaboration merges PharmaLex’s global expertise with MEPHARMA’s top-notch services, aiming to strengthen capabilities in Development Consulting, Regulatory Affairs, Pharmacovigilance, and more. Dr. Thomas Dobmeyer, CEO of PharmaLex, and Mr. Ayman Mahmoud of MEPHARMA expressed excitement about the collaboration’s potential to deliver exceptional support to clients in the region.

PharmaLex today confirmed the signing of a collaboration agreement with MEPHARMA Consultancy to establish a partnership focused on serving the clients in the Middle East region by providing various services in pharma, biotech and medical device industries. This novel partnership will combine the extensive resources and expertise of an international, global company and top-notch service provider company in support of MEPHARMA’s goal of building a strategic partnership in Development Consulting, Regulatory Affairs, Pharmacovigilance, Epidemiology & Risk Management, and Quality Management & Compliance capabilities.

“PharmaLex is proud to partner with MEPHARMA, an organization that shares PharmaLex’s commitment,” said Dr. Thomas Dobmeyer, CEO. “This partnership is another step forward in PharmaLex’s strategy to grow our business in the Middle East

region”.

“Today marks another key milestone in MEPHARMA’s ongoing quest to our reach,” said Mr. Ayman Mahmoud. “This venture between MEPHARMA and PharmaLex aims to provide and support each other.”